Aptevo Biotherapeutics Llc competitive analysis

Explore patent oppositions filed by Aptevo Biotherapeutics Llc against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 10, 2026
Patent NumberTitleApplicantOpposition Date
Recombinant Co-Expression Of Vitamin K Epoxide Reductase Subunit 1 To Improve Vitamin K Dependant Protein ExpressionBAXALTAJun 18, 2018

Explore Aptevo Biotherapeutics Llc's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 10, 2026
Patent NumberPublication DateTitleTotal Oppositions
Dec 13, 2017Method Of Producing Biologically Active Vitamin K Dependent Proteins By Recombinant Methods1

Latest PTAB cases involving Aptevo Biotherapeutics Llc

Discover the latest PTAB cases involving Aptevo Biotherapeutics Llc, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Aptevo Biotherapeutics Llc with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 10, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
APTEVO BIOTHERAPEUTICS LLC11 - -
BAXALTA2026 - -
BAXALTA INCORPORATED - 26 - -
BAXTER1447515